Hawaii · 2025 Regular Session · Resolution

SR 4: REQUESTING THE AUDITOR TO ASSESS BOTH THE SOCIAL AND FINANCIAL EFFECTS OF PROPOSED MANDATED HEALTH INSURANCE COVERAGE FOR A PERCENTAGE OF THE COSTS OF INTRAVENOUS KETAMINE THERAPY TO TREAT DEPRESSION.

In committee Last action March 24, 2025: The committee on HHS deferred the measure.

Plain-language summary

SR 4 is a resolution introduced in the Hawaii Senate on January 30, 2025. According to its official title, it concerns: REQUESTING THE AUDITOR TO ASSESS BOTH THE SOCIAL AND FINANCIAL EFFECTS OF PROPOSED MANDATED HEALTH INSURANCE COVERAGE FOR A PERCENTAGE OF THE COSTS OF INTRAVENOUS KETAMINE THERAPY TO TREAT DEPRESSION. Primary sponsor: Kurt Fevella (Republican). Most recent recorded action (March 24, 2025): The committee on HHS deferred the measure.

Sponsors

Primary sponsor: Kurt Fevella (Republican).